Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +8.48%
#3 Fake World Assets Fake World Assets +4.62%
#4 Dual Dual +3.58%
#5 Figure Heloc Figure Heloc +3.49%
#6 Movement Movement +3.22%
#7 Ontology Gas Ontology Gas +2.75%
#8 HOME HOME +2.62%
#9 The Black Bull The Black Bull +2.59%
#10 Orochi Network Orochi Network +2.47%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Kedudukan dalam Saham #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Harga Saham
$0.00953895
Disegerakkan terakhir: 2024-05-22
Modal Pasaran
$1.28M
Perubahan (1 hari)
0.06%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Evgen Pharma plc (EVG)

Kategori

Healthcare
Pendapatan untuk Evgen Pharma plc (EVG)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Evgen Pharma plc, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Evgen Pharma plc dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE